F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
September 20, 2024
0
Comments
9 Views
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.